AYLA

Ayala Pharmaceuticals (AYLA)

Ayala Pharmaceuticals Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:AYLA

1 2 3 4 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2023/02/09	07 : 17	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:AYLA	Ayala Pharmaceuticals Inc
2023/02/07	04 : 50	Edgar (US Regulatory)	Schedule 13g (sc 13g/a)	NASDAQ:AYLA	Ayala Pharmaceuticals Inc
2023/01/26	06 : 54	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AYLA	Ayala Pharmaceuticals Inc
2023/01/25	00 : 22	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AYLA	Ayala Pharmaceuticals Inc
2023/01/24	20 : 07	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:AYLA	Ayala Pharmaceuticals Inc
2023/01/24	20 : 07	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:AYLA	Ayala Pharmaceuticals Inc
2023/01/20	05 : 52	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:AYLA	Ayala Pharmaceuticals Inc
2023/01/20	05 : 44	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:AYLA	Ayala Pharmaceuticals Inc
2023/01/20	05 : 43	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:AYLA	Ayala Pharmaceuticals Inc
2023/01/20	05 : 33	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)	NASDAQ:AYLA	Ayala Pharmaceuticals Inc
2023/01/14	06 : 02	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AYLA	Ayala Pharmaceuticals Inc
2023/01/05	07 : 04	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AYLA	Ayala Pharmaceuticals Inc
2022/11/24	06 : 04	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AYLA	Ayala Pharmaceuticals Inc
2022/11/18	06 : 36	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AYLA	Ayala Pharmaceuticals Inc
2022/11/05	05 : 38	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:AYLA	Ayala Pharmaceuticals Inc
2022/11/04	05 : 08	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:AYLA	Ayala Pharmaceuticals Inc
2022/10/20	06 : 11	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:AYLA	Ayala Pharmaceuticals Inc
2022/10/20	06 : 07	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AYLA	Ayala Pharmaceuticals Inc
2022/10/11	17 : 46	TipRanks	H.C. Wainwright Reaffirms Their Buy Rating on Ayala Pharmaceuticals (AYLA)	NASDAQ:AYLA	Ayala Pharmaceuticals Inc
2022/10/11	17 : 45	TipRanks	Noble Financial Reaffirms Their Hold Rating on Ayala Pharmaceuticals (AYLA)	NASDAQ:AYLA	Ayala Pharmaceuticals Inc
2022/09/27	23 : 11	TipRanks	Ayala Pharma (NASDAQ:AYLA) Bags fast Track Status for Desmoid Tumor Candidate	NASDAQ:AYLA	Ayala Pharmaceuticals Inc
2022/09/27	21 : 58	Dow Jones News	Ayala Pharmaceuticals Gets Fast-Track Designation for AL102 Cancer Treatment	NASDAQ:AYLA	Ayala Pharmaceuticals Inc
2022/09/19	19 : 25	TipRanks	H.C. Wainwright Sticks to Their Buy Rating for Ayala Pharmaceuticals (AYLA)	NASDAQ:AYLA	Ayala Pharmaceuticals Inc
2022/09/13	21 : 05	TipRanks	Ayala Pharmaceuticals (AYLA) Receives a Buy from Noble Financial	NASDAQ:AYLA	Ayala Pharmaceuticals Inc
2022/09/12	21 : 16	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AYLA	Ayala Pharmaceuticals Inc
2022/08/17	21 : 05	TipRanks	Noble Financial Keeps Their Buy Rating on Ayala Pharmaceuticals (AYLA)	NASDAQ:AYLA	Ayala Pharmaceuticals Inc
2022/08/17	05 : 40	AllPennyStocks.com	Q2 Financial Results Send Micro Cap Soaring	NASDAQ:AYLA	Ayala Pharmaceuticals Inc
2022/08/16	05 : 21	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:AYLA	Ayala Pharmaceuticals Inc
2022/07/27	21 : 25	TipRanks	Noble Financial Thinks Ayala Pharmaceuticals’ Stock is Going to Recover	NASDAQ:AYLA	Ayala Pharmaceuticals Inc
2022/07/27	03 : 24	TipRanks	Ayala Pharmaceuticals Stock Nearly Triples on Desmoid Tumor Treatment News	NASDAQ:AYLA	Ayala Pharmaceuticals Inc